Deep Track Capital »

Immix Biopharma shares owned by Deep Track Capital

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $29M 2.8M 10.31

More positions owned by Deep Track Capital

Guardant Health (GH)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Vaxcyte (PCVX)
Alnylam Pharmaceuticals (ALNY)
Veradermics Common Stock (MANE)
Genmab A/s Sponsored Ads (GMAB)
Tarsus Pharmaceuticals (TARS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Ocular Therapeutix (OCUL)
BioMarin Pharmaceutical (BMRN)
Nurix Therapeutics (NRIX)
Oruka Therapeutics (ORKA)
Alumis (ALMS)

View all positions for Deep Track Capital

Top funds holding Immix Biopharma

Jupiter Topco
Henderson Group
Saturn V Capital Management
Eventide Asset Management
BlackRock
Deep Track Capital
Vanguard Capital Management
Opaleye Management
Millennium Management
UBS Group
Marshall Wace
Wellington Management Company
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Velan Capital Investment Management

View all funds holding Immix Biopharma